SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST). This is an ...
American BRCA outcomes and utilization of testing (ABOUT) study. Health and quality of life (QOL) issues in four groups of lung cancer patients: Low-dose computed tomography (LDCT) screened, chest ...
Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results